Elekta AB ADR EKTAY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.42
- Day Range
- $5.57–5.59
- 52-Week Range
- $4.35–6.93
- Bid/Ask
- $4.35 / $7.46
- Shares Outstanding
- 382.08M
- Market Cap
- $2.13B
- Volume/Avg
- 4,555 / 3,370
Key Statistics
- Price/Earnings (Normalized)
- 15.21
- Price/Sales
- 1.20
- Dividend Yield (Trailing)
- 4.63%
- Dividend Yield (Forward)
- 4.63%
- Total Yield
- 4.63%
Company Profile
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 4,353
- Website
- https://www.elekta.com
Competitors
Valuation
|
Metric
|
EKTAY
|
BDX
|
SHL
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.21 | 14.11 | 18.16 |
Price/Book Value | 2.80 | 2.05 | 2.30 |
Price/Sales | 1.20 | 2.59 | 1.90 |
Price/Cash Flow | 11.40 | 13.84 | 13.77 |
Price/Earnings
EKTAY
BDX
SHL
Financial Strength
|
Metric
|
EKTAY
|
BDX
|
SHL
|
|---|---|---|---|
Quick Ratio | 0.62 | 0.36 | 0.74 |
Current Ratio | 0.87 | 0.94 | 1.16 |
Interest Coverage | 0.29 | 3.53 | 7.88 |
Quick Ratio
EKTAY
BDX
SHL
Profitability
|
Metric
|
EKTAY
|
BDX
|
SHL
|
|---|---|---|---|
Return on Assets (Normalized) | 3.29% | 4.97% | 5.00% |
Return on Equity (Normalized) | 11.19% | 10.63% | 12.25% |
Return on Invested Capital (Normalized) | 6.97% | 7.26% | 12.99% |
Return on Assets
EKTAY
BDX
SHL
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|pm%Mfpv | LOCK|T@K$ | $193B | |||
| Stryker Corp
SYK
| LOCK|<?Vyb&!% | LOCK|?> | $130B | |||
| Medtronic PLC
MDT
| LOCK|$YFTr^ | LOCK|R#@m | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|q!>!V# | LOCK|Nxj^@ | $75B | |||
| Edwards Lifesciences Corp
EW
| LOCK|%LSndFT$ | LOCK|kGFb> | $53B | |||
| DexCom Inc
DXCM
| LOCK|dpx?g>! | LOCK|ryHRd | $34B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<>Z$%yC | LOCK|<!V | $33B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%Kq | LOCK|<<& | $27B | |||
| Steris PLC
STE
| LOCK|>x>lN% | LOCK|p$G^ | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|b>l?<%n^ | LOCK|LD | $19B |
United States